Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • SARS-CoV
    (2)
  • Virus Protease
    (2)
  • Antibacterial
    (1)
  • Phosphatase
    (1)
  • Raf
    (1)
  • Ras
    (1)
  • Others
    (5)
TargetMol | Tags By Natures
  • Sigesbeckia
    (1)
TargetMol | Tags By ResearchField
  • Infection
    (3)
  • Cancer
    (1)
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

T3817

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    7
    TargetMol | All_Pathways
  • Natural Products
    3
    TargetMol | Natural_Products
Darutigenol
T38175940-00-1
Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
  • $97
In Stock
Size
QTY
Muramic acid HCl
Muramic acid HCl(1114-41-6 Free base)
T38176L55226-93-2In house
Muramic acid HCl is part of the peptidoglycan in the cell wall of many Gram-positive bacteria.
  • $195
In Stock
Size
QTY
RMC-0331
RM-023
T381702488788-52-7
RMC-0331 (RM-023) is an orally available and potent SOS1 inhibitor with potential anticancer activity, blocking RAS activation by disrupting RAS-SOS1 interactions.
  • $89
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Propargylcholine
Propargylcholine (bromide)
T38173111755-76-1
Propargylcholine (Propargylcholine (bromide)) is an alkyne-modified choline analog and inhibits choline catabolism at the level of Dgc enzyme-catalyzed dimethylglycine demethylation in Pseudomonas aeruginosa.
  • $30
In Stock
Size
QTY
Mpro inhibitor N3 hemihydrate
T38174
Mpro inhibitor N3 hemihydrate is a potent antagonist of the SARS-CoV-2 main protease (Mpro), with an EC50 of 16.77 μM against SARS-CoV-2. It specifically inhibits Mpro in various coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E (IC50 4.0 μM), FIPV (IC50 8.8 μM), and MHV-A59 (IC50 2.7 μM) [1][2].
  • $115
Inquiry
Size
QTY
MPro N3
T38175884650-98-0
Coronavirus main protease (Mpro) inhibitor (respective IC50 values are 2.7, 4 and 8.8 μM for MHV-A29, HCoV-229E and FOPV replication in vitro). Inhibits viral cell infection in an MHV plaque reduction assay. Also inhibits SARS-CoV-2 viral cell entry in a plaque reduction assay (IC50 = 16.8 μM).
  • $630
35 days
Size
QTY
C16 3'-sulfo galactosylceramide (d18:1/16:0)
C16 3'-sulfo Galactosylceramide (d18:1/16:0)
T3817989771-78-8
C16 3'-sulfo galactosylceramide (d18:1/16:0) is a sulfated glycolipid. C16 3'-sulfo galactosylceramide (d18:1/16:0) is a relatively abundant sulfide found in porcine brain and plasma that decreases throughout development in mice. C16 3'-sulfo galactosylceramide (d18:1/16:0) is a relatively abundant sulfide found in porcine brain and plasma that decreases throughout development in mice. C16 3'-sulfo galactosylceramide (d18:1/16:0) is a relatively abundant sulfide found in porcine brain and plasma that decreases throughout development in mice. C16 3'-sulfo galactosylceramide (d18:1/16:0) inhibits retinal ganglion cell growth in vitro. C16 3'-sulfo galactosylceramide (d18:1/16:0) has been used as an internal standard for quantifying C16 3'-sulfo galactosylceramide (d18:1/16:0) in rat cerebellum and white matter isolated from patients with multiple sclerosis. reference for sulphides.
  • $1,760
Inquiry
Size
QTY